European Archives - Page 1053 of 1553 - European Medical Journal

How Long Do Antibodies Persist After COVID-19?

Although there was variation between individual patients’ antibody levels, the researchers found the overall trend of rapid reduction to be consistent.

Maternal Allergies Can Be Shared Across the Placenta

Allergic responses can be passed to newborns: a recent research demonstrates the effect of antibodies crossing the placenta during pregnancy.

Prostate Cancer Screening Recommendations in Western Nations

Prostate cancer (PCa) was the most commonly diagnosed malignancy in 105 countries in 2018 and the fifth leading cause of cancer deaths in males…

EMJ Oncology 8.1 2020 Feature Image

Review of the European Society for Medical Oncology (ESMO) Virtual Congress 2020

MADRID’S stunning boulevards and awe-inspiring galleries and museums were a sorely-missed backdrop for this year’s European Society…

EMJ Oncology 8.1 2020 Feature Image

Breast Cancer in Young Females: Real-World Data to Fill the Gap

Breast cancer (BC) is the most common cause of cancer-related deaths in females under 45 years…

EMJ Oncology 8.1 2020 Feature Image

EMJ Oncology 8.1 2020

EMJ Oncology shares an impressive collection of new and interesting research, alongside our independent review of European Society for Medical Oncology (ESMO) Virtual Congress 2020 with research and breaking news from the virtual event.

EMJ Oncology 8.1 2020 Feature Image

COVID-19: Impact on Cancer Patients and Oncology Professionals

TRANSFORMATIVE is a term that appropriately describes the striking developments made in the oncology field in recent years. Yet again the…

EMJ Oncology 8.1 2020 Feature Image

Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in Europe and the UK

The global incidence of breast cancer was 1.96 million cases in 2017, making it the third highest incident cancer…

EMJ Oncology 8.1 2020 Feature Image

Next-Generation Sequencing Standard of Care for Molecular Profiling

Given that COVID-19 has posed unique challenges in cancer care, a number of speakers addressed, with evidence, the impact of COVID-19…

EMJ Oncology 8.1 2020 Feature Image

Identifying the Best Ki67 Cut-Off for Determining Luminal Breast Cancer Subtypes Using Immunohistochemical Analysis and PAM50 Genomic Classification

Gene expression profiling has a significant impact on understanding the biology of breast cancer (BC)…